Predict your next investment

Private Equity
gemny.com

See what CB Insights has to offer

Investments

28

Portfolio Exits

2

About Global Emerging Markets

GEM is an alternative investment group that manages diverse investment vehicles worldwide with different degrees of operational control, risk-adjusted return and liquidity profile. The Company's funds and investment vehicles provide GEM and its partners with exposure to: Small-Mid Cap Management Buyouts, Private Investments in Public Equities (PIPEs) and select venture investments. GEM's funds include: CITIC-GEM Fund (matured in December 2015), Kinderhook Industries (GP and LP non-voting stakes), GEM Global Yield Fund LLC SCS, GEM India and VC Bank/GEM Mena Fund (GEM exited both its GP and LP stakes in these funds in 2015 and 2010).

Global Emerging Markets Headquarter Location

590 Madison Avenue 36th Floor

New York, New York, 10022,

United States

212-582-3400

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Global Emerging Markets

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Global Emerging Markets in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Latest Global Emerging Markets News

Speed Medical SAE, Secures EGP 1.57 Billion Capital Commitment from Global Emerging Markets (GEM)

Sep 9, 2021

Speed Medical SAE, Secures EGP 1.57 Billion Capital Commitment from Global Emerging Markets (GEM) Cairo, Egypt, Speed Medical Company (EGX: SPMD), today announced a EGP 1.57 billion capital commitment from GEM Global Yield LLC SCS (“GGY”), the Luxembourg based private alternative investment group. Under the agreement, GGY will provide Speed Medical Co. (SPMD) with a Share Subscription Facility of up to EGP 1,570 million for a 36-month term to use at its discretion, subject to agreed upon terms. The company will have no minimum drawdown obligation and is authorized to utilize the facility on an as-need basis over the life of the agreement. “We are pleased to receive what we believe is potentially lower cost and less dilutive financing, as the company controls the timing and amount of each drawdown. The new facility will provide financing that can be deployed for acquisitions, our aggressive expansion plans, new venture financing as well as consolidating current bank obligations. The facility will help the company to maintain its growth and at the same time start distributing cash dividends to its shareholders commencing in the coming year” – Chairman of SPMD, Mahmoud Lasheen, was quoted.

Global Emerging Markets Investments

28 Investments

Global Emerging Markets has made 28 investments. Their latest investment was in Unified Chemicals as part of their Private Equity on September 9, 2021.

CBI Logo

Global Emerging Markets Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/7/2021

Private Equity

Unified Chemicals

$17.73M

Yes

1

9/2/2021

Line of Credit

Zo World

$17.8M

Yes

1

8/19/2021

Line of Credit

Captura Biopharma

Yes

1

8/6/2021

Line of Credit

Subscribe to see more

$99M

Subscribe to see more

10

7/29/2021

PIPE

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/7/2021

9/2/2021

8/19/2021

8/6/2021

7/29/2021

Round

Private Equity

Line of Credit

Line of Credit

Line of Credit

PIPE

Company

Unified Chemicals

Zo World

Captura Biopharma

Subscribe to see more

Subscribe to see more

Amount

$17.73M

$17.8M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

1

10

10

Global Emerging Markets Portfolio Exits

2 Portfolio Exits

Global Emerging Markets has 2 portfolio exits. Their latest portfolio exit was Ensysce Biosciences on June 30, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/30/2021

Reverse Merger

$991

4

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

6/30/2021

00/00/0000

Exit

Reverse Merger

Subscribe to see more

Companies

Subscribe to see more

Valuation

$991

Acquirer

Subscribe to see more

Sources

4

10

Global Emerging Markets Team

3 Team Members

Global Emerging Markets has 3 team members, including current Managing Director, Peter de Svastich.

Name

Work History

Title

Status

Peter de Svastich

Managing Director

Current

Anne Frank-Shapiro

Pegasus Capital Advisors, Credit Suisse, and IBD

Chief Operating Officer

Former

Suneel Kaji

The Rohatyn Group, Everstone Capital, Accordion Partners, and University of Texas Investment Management Company

Managing Director

Former

Name

Peter de Svastich

Anne Frank-Shapiro

Suneel Kaji

Work History

Pegasus Capital Advisors, Credit Suisse, and IBD

The Rohatyn Group, Everstone Capital, Accordion Partners, and University of Texas Investment Management Company

Title

Managing Director

Chief Operating Officer

Managing Director

Status

Current

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.